Addressing the global burden of chronic kidney disease through clinical and translational research
about
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapiesEffectiveness of management models for facilitating self-management and patient outcomes in adults with diabetes and chronic kidney diseaseAltitude and regional gradients in chronic kidney disease prevalence in Costa Rica: Data from the Costa Rican Longevity and Healthy Aging Study.Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients.Psychosocial Interventions for Depressive and Anxiety Symptoms in Individuals with Chronic Kidney Disease: Systematic Review and Meta-Analysis.Detection of Chronic Kidney Disease by Using Different Equations of Glomerular Filtration Rate in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Analysis.Renal insufficiency was correlated with 2-year mortality for rural female patients with ST-segment elevation acute myocardial infarction after reperfusion therapy: a multicenter, prospective study.Chronic kidney disease in low- and middle-income countriesInappropriateness of medication prescriptions about chronic kidney disease patients without dialysis therapy in a Chinese tertiary teaching hospital.Prevalence, incidence and associated mortality of cardiovascular disease in patients with chronic kidney disease in low- and middle-income countries: a protocol for a systematic review and meta-analysis.Experiences of patients undergoing dialysis who are from ethnic and racial minorities.Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair.Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats.Endoplasmic reticulum stress inhibition attenuates hypertensive chronic kidney disease through reduction in proteinuria.Does Selection and Management of Patients with Chronic Kidney Disease In Government Run and Private Hospitals Differ?Targeting neural reflex circuits in immunity to treat kidney disease.Dialysis Provision and Implications of Health Economics on Peritoneal Dialysis Utilization: A Review from a Malaysian Perspective.Joubert's syndrome and related disorders and home-based peritoneal dialysis in East Africa: a case report.Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease.Women and Kidney Diseases: Questions Unanswered and Answers Unquestioned.What we know and do not know about women and kidney diseases; Questions unanswered and answers unquestioned: Reflection on World Kidney Day and International Woman's Day.What We Do and Do Not Know About Women and Kidney Diseases; Questions Unanswered and Answers Unquestioned: Reflection on World Kidney Day and International Woman's Day.Factors influencing dialysis withdrawal: a scoping review.What We Do and Do Not Know about Women and Kidney Diseases: Questions Unanswered and Answers Unquestioned: Reflection on World Kidney Day and International Women's Day.What we do and do not know about women and kidney diseases; questions unanswered and answers unquestioned: reflection on World Kidney Day and International Woman's Day.The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial
P2860
Q26744317-592BF9EC-CEB5-4882-979C-F3EF0D7D6F86Q28086936-88D9D221-312E-4B14-97EC-E4911BEBD541Q31004944-9A43F224-31B8-42D6-AC5A-EB257EBB8D99Q33604689-7BFF099D-13D1-48B9-BEC4-48CD1CC555B4Q33790497-F9EE9838-50EB-477C-A99C-7824E3BDFBDCQ33905162-A6D62D83-BC9B-4077-A785-69133E742BC8Q35878084-C4EF51A1-53CF-4FC7-B676-1F63658CEC32Q36926927-0D4C209F-B15D-48DF-93C2-EA98B41D449EQ37344488-B47A9ABA-D2D7-4EA4-BC3C-320D72A49FE2Q38603171-2059D1E6-260A-4E5A-935F-8B796A50B255Q39099063-790147B8-F578-4C46-9F1B-821A3D66F8DEQ39238366-8E9340D3-06B5-4DFE-9009-0265F5B95DD1Q41547300-D7DE1A43-7CC5-4144-A60A-1DCC6E75B4F0Q42170580-AE58B36D-A4E9-4A8E-B05B-5B6F3C1F02ADQ42252721-AB65D186-8E15-4E04-812F-CDA72AE8DA76Q45069057-257FBCF2-7EB9-4A39-BF74-C72DDBBE2C4DQ46225939-374BEEC2-47B5-4258-8198-3A0F9D54A9D1Q46478045-AFFBFABA-6046-4E38-91CF-53E4B0C541F8Q52678097-1F343530-BD53-4C87-9A3C-6985BBFF3AE7Q54959867-DE3B522E-0846-48B4-9786-8EBF04F25931Q55102288-A0121D35-E371-4477-967F-49FEE0254AB0Q55171784-B39F30CA-10E4-4ECC-AE7B-AF0D2EC6BD8FQ55280793-38575C87-A1FA-4C9A-93BF-8190A8B6DE2DQ55331903-CDC2AF49-B72B-4A9E-AFE7-B5013B02BC36Q55446390-FAC9BBDB-71B8-41E9-8C9F-136EA1A43064Q58792844-A2A70A7F-4B19-44CD-B1C3-625B990AB720
P2860
Addressing the global burden of chronic kidney disease through clinical and translational research
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Addressing the global burden o ...... cal and translational research
@ast
Addressing the global burden o ...... cal and translational research
@en
Addressing the global burden o ...... cal and translational research
@nl
type
label
Addressing the global burden o ...... cal and translational research
@ast
Addressing the global burden o ...... cal and translational research
@en
Addressing the global burden o ...... cal and translational research
@nl
prefLabel
Addressing the global burden o ...... cal and translational research
@ast
Addressing the global burden o ...... cal and translational research
@en
Addressing the global burden o ...... cal and translational research
@nl
P2860
P3181
P1476
Addressing the global burden o ...... cal and translational research
@en
P2093
P2860
P304
229-43; discussion 243-6
P3181
P407
P577
2014-01-01T00:00:00Z